Cervical adenosquamous carcinoma accounts for 8%10% of cervical cancer, containing two components要squamous cell carcinoma and adenocacinoma. Both the proportions and differentiation of these two components may be different. The poorly differentiated carcinoma is easy to relapse and metastasize, with high degree of malignancy and poor prognosis. 
adenosquamous carcinoma group. The average times of gravidity and parturition were 3.3 依 2.1 (range, 014) and 1.8 依 1.4 (range, 04) in cervical adenocarcinoma group, 3.4 依 1.7 (range, 18) and 1.9 依 1.1 (range, 16) in cervical adenosquamous group.
Among the patients of FIGO stages IBIIA, those with tumor diameter less than 4 cm underwent radical hysterectomy and pelvic lymphadenectomy, those with tumor diameter more than 4 cm were usually treated with neoadjuvant chemotherapy and (or) radiotherapy at first, and underwent radical hysterectomy and pelvic lymphadenectomy after local tumor shrank. The patients of FIGO stages II BIIIA were usually treated with neo adjuvant chemotherapy and (or) afterloading therapy firstly, and underwent radical surgery after local tumor shrank. Those patients of FIGO stages IIBIIIA who had unresectable tumor and those had tumors beyond stage IIIA received curative radiotherapy. Postoperative adjuvant radiotherapy (external irradiation of 40 Gy) and (or) chemotherapy was given to the patients with high risk factors such as tumor diameter more than 4 cm, lymph node metastasis, parametrial involvement and positive vaginal margins. At present, combined chemotherapy, such as TP, CP, DF and PFM regimens, was mainly used.
The patients were followed up mainly by telephone or letter since the time of diagnosis. The median followup period was 32 months (range, 1293 months). Patients lost of followup were considered as censored data. SPSS13.0 software was used for statistical analyses. Enumeration data were analyzed by Chisquare test. Survival was analyzed by KaplanMeier method. Intergroup comparison was performed by logrank test. Multivariable analysis was conducted using Cox regression model. Statistical significance was defined as 臆0.05.
The proportion of bulky tumor (maximal diameter of more than 4 cm) was significantly lower in cervical adenocarcinomas than in cervical adenosqumous carcinomas ( < 0.05); the proportions of FIGO stages IIBIV tumor and poorly differentiated tumor were significantly lower in adenocarcinomas than in adenosquamous carcinomas ( < 0.05) ( Table 1) .
Parametrial involvement was noted in 12.5% of adenocarcinoma patients and 18.2% of adenosquamous carcinoma patients ( > 0.05). Lymph node metastasis was found in 27.3% of adenocarcinoma patients and 31.8% of adenosquamous carcinoma patients ( > 0.05). Among the 79 adenocarcinoma patients who underwent surgical operation, 70 (88.6% ) underwent radical hysterectomy plus pelvic lymphade鄄 nectomy, and 9 (11.4% ) underwent other surgical operations (radical hysterectomy plus unilateral oophorectomy, contralateral ovarian transposition and pelvic lymphadenectomy, radical hysterectomy plus bilateral salpingooophorectomy and pelvic lymphadenectomy); among the 40 adenosquamous carcinoma patients who underwent surgical operation, 37 (92.1%) underwent radical hysterectomy plus pelvic lymphadenectomy, and 3 (7.9%) underwent other surgical operations. No significant difference was noted between the two groups ( > 0.05) ( Table 1 ).
Univariate analysis showed that tumor size, FIGO stage, stromal invasion and lymph node metastasis were significant factors for both diseasefree and overall survival ( < 0.05), while age, degree of differentiation, parametrial involvement, ovary reservation and preoperative or postoperative adjuvant therapy had no effect on overall survival (OS) and diseasefree survival (DFS) (Table 2, Figures 1 and 2) .
Cox regression multivariate analysis showed that FIGO stage and lymph node metastasis were independent factors affecting both OS and DFS. The later the FIGO stage, the worse the prognosis; the earlier the lymph node metastasis, the worse the prognosis (Table 3) . Of the 8 cervical adenosquamous carcinoma patients who had metastasis, 4 had bone metastasis, 2 had pelvic cavity metastasis, and 2 had lung metastasis; of the 18 cervical adenocarcinoma patients who had tumor recurrence or metastasis, 8 had pelvic cavity metastasis, 2 had lung metastasis, 3 had liver and lung metastasis, and 3 had local recurrence. The recurrence and metastasis rates of adenosquamous carcinoma and adenocarcinoma were 22.2% and 25.7% , respectively ( > 0.05). According to the results of prognostic analysis, patients were divided into highrisk group (tumor diameter of more than 4 cm, depth of stromal invasion of more than 1/2 layer, lymph node metastasis) and lowrisk group (tumor diameter of no more than 4 cm, depth of stromal invasion of no more than 1/2 layer, no lymph node metastasis). No significant differences were observed in the DFS between adenocarcinoma group and adenosquamous carcinoma group ( > 0.05), in recurrence rate between adjuvant therapy group and nonadjuvant therapy group as well as between lowrisk group and highrisk group ( > 0.05) ( Table 4) .
As stratified by age, FIGO stage, tumor diameter, infiltration depth, lymph node metastasis, ovarian reservation and preoperative or postoperative radiotherapy and chemotherapy, no significant differences in 2year OS and DFS rates were observed between adenocarcinoma and adenosquamous carcinoma groups ( > 0.05), suggesting that there was no statistical difference in prognosis between the two groups.
Cervical cancer is one of the most common gynecologic malignancies. Cervical adenosquamous carcinoma accounts for 3% 5% of cervical cancer. It comes into being that the reserve cells develop into gland cells and squamous cells at the same time and it contains two componentsadenocarcinoma and squamous cell carcinoma. 4 It has been reported that pathologic types had no significant effect on prognosis, 5 while Farley .
2 considered that adenosquamous carcinoma was an independent prognostic factor, especially for advanced stage patients. It is necessary to analyze clinicopathologic characteristics and prognosis of cervical adensquamous carcinoma as a separate pathologic type. The incidence of cervical adenosquamous carcinoma is lower than those of other types of cervical cancer, but it is inconsistent in the literature. Yasuda . 6 reported that adenosquamous carcinoma accounted for 5%10% of cervical cancer, Takac . 7 reported 5.3% , Le . 4 reported 3% 5% . In this study, cervical adenosquamous carcinoma accounted for 2.4% of cervical cancer and its incidence was low.
We compared the clinicopathologic characteristics of adenocarcinoma and adenosquamous carcinoma, and found that tumor size and histological grade were statistically different. It was consistent with the literature. 5 Wang . 8 discovered that poorly differentiated tumor and lymph node metastasis were more common in cervical adenosquamous carcinoma and its histological behavior was more aggressive than cervical adenocarcinoma. Yasuda . 6 compared 28 cases of stage IB1 adenosquamous carcinoma with stage IB1 adenocarcinoma and squamous cell carcinoma, and found that lymph node metastasis rates were 21.4% , 13.6% and l5.8% , respectively, indicating that adenosquamous carcinoma was more aggressive. Among the 44 cases of adenosquamous carcinoma in our study, 25 (56.8% ) were poorly differentiated, and 14 (31.8%) were with lymph node metastasis. It confirmed the above conclusion.
It is mostly reported that the later the FIGO stage of cervical cancer, the broader the surrounding invasion and the greater the risk of lymph node metastasis; the larger the tumor diameter, the greater the risk of parametrial invasion; the deeper the tumor invasion, the greater the risk of lymph node metastasis.
9,10 These are significant prognostic factors of cervical adenosquamous carcinoma. Our univariate analysis showed that FIGO stage, tumor size, lymph node metastasis and depth of stromal invasion 
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had dramatic impact on prognosis of cervical adenosquamous carcinoma, which was consistent with the literature.
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Our multivariate analysis showed that FIGO stage and lymph node metastasis were important factors for prognosis of adenosquamous carcinoma, which was in accordance with the results of Li . 11 It is still disputed that whether different pathologic types affect prognosis. Farley . 2 pointed out that the 5year survival rate of cervical adenosquamous carcinoma patients was much lower than that of adenocarcinoma patients, but the difference only exist among advanced stage patients, not among stage I patients. Lea . 12 found that the patients with stage IB1 adenosquamous carcinoma were easy to have tumor relapse with a low survival rate. Cai . 13 also discovered that the prognosis of adenosquamous carcinoma patients was poor. In contrast, Irie . 3 reported that there was no difference in survival rates between them. In our study, the prognosis of adenosquamous carcinoma and adenocarcinoma patients were similar, which may lie in the following reasons: (1) the followup time was short, (2) the sample size was small, especially that of advanced tumor, which could not reflect the clinical stage distribution characteristic of adenosquamous carcinoma. dosReis . 5 and Lai . 14 reported that there was no significant difference in recurrence rate between adenosquamous carcinoma and adenocarcinoma as well as squamous carcinoma. There was no statistical difference in recurrence rate and timetorecurrence between adenosquamous carcinoma and adenocarcinoma in our study. It may be associated with higher proportion of early stage patients.
In conclusion, cervical adenosquamous carcinoma, with a low incidence, is characterized by large tumor size, poor differentiation and high invasion. FIGO stage and lymph node metastasis are significant prognostic factors. According to our results, the prognosis of adenosquamous carcinoma and adenocarcinoma are similar, therefore, comprehensive treatment based on radical surgery is still the main treatment at present. For those patients with large tumor and can not tolerate operation, radiotherapy and chemotherapy should be performed firstly, operation would be performed later when appropriate.
